… with COPD concurrently treated with bronchodilators, an anticholinergic bronchodilator
should be … In an exaggerated form, such a phenomenon has been described in asthma, where …

… with long-acting muscarinic antagonists (LAMAs) or long-acting … of and/or findings suggestive
of asthma-COPD overlap. … Anti-cholinergic and long-acting bronchodilators were removed …

COPD and asthma have different risk factors and pathogenesis, but they share a … small
airways dysfunction in COPD and asthma and the effect of bronchodilators and inhaled steroids …

… This chapter reviews the development of the treatments of asthma and COPD particularly …
generations of short- and long-acting β-agonists. It reviews asthma death epidemics, considers …

… Strong evidence supports the efficacy of bronchodilators in managing symptoms, improving
… with COPD, and treatment with long-acting muscarinic antagonists (LAMAs) and long-acting …

… /long-acting muscarinic antagonist/long-acting β 2 -agonist (… in patients with chronic obstructive
pulmonary disease (COPD) … Patients with a current diagnosis of asthma or other clinically …

… This study aimed to compare the effectiveness of long-acting bronchodilator treatments,
LABA and LAMA in group A COPD patients. The number of participants with improvement in …

… to inhaled corticosteroid/long-acting beta-… novel molecules that exploit this activity of
azithromycin, while minimizing antibacterial activity, as drugs for the treatment of asthma and COPD. …

… asthma or COPD alone. Some guidelines for ACO recommend triple therapy with inhaled
corticosteroids, long-acting β2 agonists, and long-acting … UMEC, the novel LAMA used as an …

… Long-acting bronchodilators have been recognized as the mainstay of the treatment of stable
COPD, while ICS are usually added in patients with COPD … who have concurrent asthma or …